Prostate cancer is one the most relevant cancers and a leading cause of morbidity and mortality among men worldwide (
19,
20). In Iran, there are no accurate data about the incidence of prostate cancer, but it is estimated that around 90,000 new cases of cancer are reported annually, of which 12 per 100000 cases are prostate cancer (
21). The presence of
P. acnes was strongly correlated with chronic inflammation, suggesting that this bacterium may have a potential role in cancer development (
22). Until now, there are scarce studies conducted to evaluate the prevalence of
P. acnes in PCa or BPH. As far as we know, there is no exact data about this issue reported from Iran. Therefore, we investigated the possible role of
P. acnes in PCa and BPH using PCR standard methods. Based on the results of the present study, 68.4% of the PCa tissue samples contained
P. acnes DNA. About 58% of the BPH tissue samples as the control group were positive for this bacterium, too. Although the positive rate was higher in PCa than in BPH specimens, there was no statistical significance between these differences. This may be due to that we could not use healthy tissue samples as the control group. Investigators showed the role of chronic or recurrent inflammatory processes in the progression of BPH and prostate cancer (
23,
24). The high rate of positive results for
P. acnes in BPH tissues may consider this bacterium as a predisposing factor for BPH, as well as PCa. Cohen et al. in 2005 showed the presence of
P. acnes in one-third of PCa tissue samples as the most common detected microorganism (
25). By using fluorescence in situ hybridization, another study in 2007 reported the presence of
P. acnes in 50% of the radical prostatectomy specimens (
26).
P. acnes was the most commonly cultured microorganism (17%) from prostate samples in the study performed by Sfanos et al. (
24). Unequal tissue sample size and difference in bacterial detection methods may explain the discrepancy between the results of different studies. Similar to the current study, Davidsson et al. evaluated the relationship between
P. acnes and PCa on 100 cancerous and 50 non-cancerous samples by standard PCR. Based on the results of this study, the prevalence of
P. acnes in patients with PCa and control group was 60% and 26%, respectively, which indicates a high prevalence of
P. acnes in the cancer group compared to the control group (
27). The results of Davidsson et al. in the cancer group confirm the findings of our study on the high prevalence of
P. acnes in cancerous specimens. In other words, in both studies, the prevalence of
P. acnes is lower in the control group than in the PCa group. The only difference between the results of these two studies is the difference in the prevalence of
P. acnes in the control group, which is 58% in the present study in comparison with 26% in the Davidsson and colleagues study. The reason for this difference may be the use of benign samples instead of healthy samples, as the control group, in the present study. Although these specimens are not cancerous, they may have some degrees of malignancy that may affect the outcome of this study. That is why the prevalence of bacterial acne protein in the control samples of this study was higher than that of Davidsson et al. study. In addition, Davidsson et al. studied patients and healthy people in the age range of 42 to 81 years-old while in our study, the age range in both groups was 50 to 89 years. Regarding the fact that the study patients and control group were older in this study, it can justify the high prevalence of
P. acnes in the control group of this study compared to the study by Davidsson et al.